Heimdall Insights

Global Bronchiectasis Drugs Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Bronchiectasis Drugs Market was valued at $2.1 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 9.5% CAGR, to an estimated market size of $3.4 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global bronchiectasis drugs market comprises pharmaceutical interventions designed to manage and treat chronic airway dilation, including antibiotics (oral and inhaled), mucolytics, bronchodilators, and emerging anti-inflammatory biologics. The scope includes treatments for both cystic fibrosis-related and non-cystic fibrosis bronchiectasis (NCFB), focusing on reducing exacerbation frequency, managing chronic infections, and improving mucociliary clearance.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Bronchiectasis Drugs Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Antibiotics
  • Mucolytics & Bronchodilators
  • Novel Anti-inflammatories & Biologics